Press Release|

SHL Medical welcomes new CFO

New Cfo Social Media And Website 1200x630 20230428
Gwenaël Rouy-Poirier has been appointed Chief Financial Officer

SHL Medical is pleased to announce the appointment of Gwenaël Rouy-Poirier as Chief Financial Officer (CFO) of SHL and a member of the Executive Management Team as of May 2, 2023.

Gwenaël brings extensive experience as a Finance Executive with a strong track record of driving the implementation of strategic objectives as well as development initiatives. His work experience in international settings across various industries, such as aerospace, defense, and manufacturing, has given him the ability to adapt and lead teams from diverse cultural backgrounds.

“We are delighted to welcome Gwenaël, a strong finance executive, to SHL Medical and our management team. With his expertise and leadership skills, he will play a crucial role as we continue to execute on our growth strategy”, says Ulrich Faessler, CEO of SHL Medical.

“I am excited and humbled to join SHL Medical with its unique positioning in the MedTech industry”, adds Gwenaël Rouy-Poirier, incoming CFO of SHL Medical. “I look forward to working with the team to continue to drive financial performance and contribute to the achievement of the strategic roadmap.”

Gwenaël most recently served as Executive Vice President Finance and Group CFO at GKN Aerospace, where he established a strategic plan, built a tactical path for upgraded margins, and instilled greater accountability and ownership across the business through financials.

At SHL Medical, he will continue to spearhead efforts to enhance finance excellence, including financial planning and analysis, controllership, and accounting to meet targets and execute strategy.

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News